Back to Journals » OncoTargets and Therapy » Volume 9
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trial
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
12,036 | Dovepress* | 9,197+ | 1,303 | 10,500 | |
PubMed Central* | 2,839 | 793 | 3,632 | ||
Totals | 12,036 | 2,096 | 14,132 | ||
*Since 16 November 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
3 | 0 | 0 | 0 | 1 | 2 |
View citations on PubMed and Google Scholar